Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Frontiers in immunology·2026
Same author

High Concordance between ddPCR- and NGS-Based Quantification of Donor-Derived Cell-Free DNA Percentage after Kidney Transplantation.

Clinical chemistry·2026
Same author

Improving diagnostic performance of kidney allograft rejection with a model combining relative fraction and absolute copies of donor-derived cell-free DNA-Results from 5 independent cohorts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Pathogen-specific epidemiology and clinical trajectories of fungal infections after kidney transplantation: a prospective multicenter cohort study.

BMC infectious diseases·2026
Same author

Editorial: Innovative approaches to immunogenetics and organ transplantation.

Frontiers in immunology·2026
Same author

Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays.

HLA·2026

Related Experiment Video

Updated: May 24, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption.

Christian Morath1, Luis Eduardo Becker, Albrecht Leo

  • 1Department of Nephrology, University of Heidelberg, Heidelberg, Germany. christian.morath@med.uni-heidelberg.de

Transplantation
|March 3, 2012
PubMed
Summary

A reusable non-antigen-specific immunoadsorption (IA) device offers a cost-effective alternative for ABO-incompatible kidney transplantation desensitization. This approach achieves comparable outcomes to single-use devices while potentially reducing costs.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Related Experiment Videos

Last Updated: May 24, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Medicine

Background:

  • ABO-incompatible kidney transplantation requires desensitization, often using antigen-specific immunoadsorption (IA).
  • Single-use IA devices are effective but incur high costs.

Purpose of the Study:

  • To compare the efficacy and cost-effectiveness of reusable non-antigen-specific IA versus single-use antigen-specific IA for ABO-incompatible kidney transplantation desensitization.
  • To evaluate graft survival and patient outcomes in both groups.

Main Methods:

  • Retrospective analysis of 19 patients undergoing ABO-incompatible living donor kidney transplantation between 2005 and 2010.
  • Comparison of desensitization protocols using single-use antigen-specific IA (n=6) versus reusable non-antigen-specific IA (n=12).
  • Analysis of IA treatment frequency, titer reduction, need for additional plasmapheresis, and transplant outcomes.

Main Results:

  • Both IA methods achieved significant antibody titer reduction, with non-antigen-specific IA showing a slightly higher median titer drop.
  • 100% graft survival at 18 months was observed for the 17 successfully transplanted patients.
  • No significant differences in median serum creatinine, estimated glomerular filtration rate, or urinary protein-to-creatinine ratio were found between the groups at long-term follow-up.

Conclusions:

  • Reusable non-antigen-specific IA is a viable, cost-effective option for ABO-incompatible kidney transplantation desensitization.
  • This reusable approach may also contribute to the depletion of human leukocyte antigen-alloantibodies.
  • Outcomes, including graft survival and renal function, are comparable between the two IA methods.